Home ›
Entities
› academia
› In silico exploration of amyloid‐related imaging abnormalities in the gantenerumab open‐label extension trials using a semi‐mechanistic model
In silico exploration of amyloid‐related imaging abnormalities in the gantenerumab open‐label extension trials using a semi‐mechanistic model
Research article (Alzheimer s & Dementia Translational Research & Clinical Interventions, 2022) · cited 17× · AI/ML
In silico exploration of amyloid‐related imaging abnormalities in the gantenerumab open‐label extension trials using a semi‐mechanistic model
Summary
In silico exploration of amyloid‐related imaging abnormalities in the gantenerumab open‐label extension trials using a semi‐mechanistic model is a scholarly article[1].
Key Facts
In silico exploration of amyloid‐related imaging abnormalities in the gantenerumab open‐label extension trials using a semi‐mechanistic model's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). In silico exploration of amyloid‐related imaging abnormalities in the gantenerumab open‐label extension trials using a semi‐mechanistic model. Retrieved May 24, 2026, from https://4ort.xyz/entity/in-silico-exploration-of-amyloidrelated-imaging-abnormalities-in-the-gantenerumab-openlabel-extension-trials-using-a-sem
MLA“In silico exploration of amyloid‐related imaging abnormalities in the gantenerumab open‐label extension trials using a semi‐mechanistic model.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/in-silico-exploration-of-amyloidrelated-imaging-abnormalities-in-the-gantenerumab-openlabel-extension-trials-using-a-sem.
BibTeX@misc{4ortxyz_in-silico-exploration-of-amyloidrelated-imaging-abnormalities-in-the-gantenerumab-openlabel-extension-trials-using-a-sem_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{In silico exploration of amyloid‐related imaging abnormalities in the gantenerumab open‐label extension trials using a semi‐mechanistic model}}, year = {2026}, url = {https://4ort.xyz/entity/in-silico-exploration-of-amyloidrelated-imaging-abnormalities-in-the-gantenerumab-openlabel-extension-trials-using-a-sem}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): In silico exploration of amyloid‐related imaging abnormalities in the gantenerumab open‐label extension trials using a semi‐mechanistic model — https://4ort.xyz/entity/in-silico-exploration-of-amyloidrelated-imaging-abnormalities-in-the-gantenerumab-openlabel-extension-trials-using-a-sem (retrieved 2026-05-24)
